REFERENCES
- Ahles T. A., Saykin A. J., Furstenberg C. T., Cole B., Mott L. A., Skalla K., Whedon M. B., Bivens S., Mitchell T., Greenberg E. R., Silberfarb P. M. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology 2002; 20(2)485–493, [PUBMED], [INFOTRIEVE], [CSA]
- Brandt J., Spencer M., Folstein M. The telephone interview for cognitive status. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 1988; 1: 111–117
- Brown P. D., Buckner J. C., Uhm J. H., Shaw E. G. The neurocognitive effects of radiation in adult low-grade glioma patients. Neuro-oncology 2003; 5(3)161–167, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Buckwalter J. G., Crooks V. C., Petitti D. B. A preliminary psychometric analysis of a computer assisted administration of the Telephone Interview of Cognitive Status—Modified. Journal of Clinical and Experimental Neuropsychology 2002; 24(2)169–175
- Copeland D. R., Moore B. D., 3rd, Francis D. J., Jaffe N., Culbert S. J. Neuropsychologic effects of chemotherapy on children with cancer: A longitudinal study. Journal of Clinical Oncology 1996; 14(10)2826–2835, [PUBMED], [INFOTRIEVE], [CSA]
- Desai M., Bruce M., Desai R., Druss B. Validity of self-reported cancer history: A comparison of health interview data and cancer registry records. American Journal of Epidemiology 2001; 153(3)299–306, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lesnik P. G., Ciesielski K. T., Hart B. L., Benzel E. C., Sanders J. A. Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia: Enhanced data analysis using an effect size model. Archives of Neurology 1998; 55(12)1561–1568, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Meyers C. A. Neurocognitive dysfunction in cancer patients. Oncology 2000; 14(1)75–79, [PUBMED], [INFOTRIEVE]
- O'Neill B. P., Wang C. H., O'Fallon J. R., Colgan J. P., Earle J. D., Krigel R. L., Brown L. D., McGinnis W. J. The consequences of treatment and disease in patients with primary NS non-Hodgkin's lymphoma: Cognitive function and performance status. North Central Cancer Treatment Group. Neuro-oncology 1999; 1: 1196–1203
- Petitti D. B., Buckwalter J. G., Crooks V. C., Chiu V. Prevalence of dementia in users of hormone replacement therapy as defined by prescription data. Journals of Gerontology: Series A, Biological Sciences and Medical Sciences 2002; 57(8)M532–M538
- Sands S. A., van Gorp W. G., Finlay J. L. Pilot neuropsychological findings from a treatment regimen consisting of intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Child's Nervous System 1998; 14: 587–589, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schatz J., Kramer J. H., Ablin A., Matthay K. K. Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 2000; 14(2)189–200, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Valentine A. D., Meyers C. A. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer 2001; 92(6 Suppl)1694–1698, [PUBMED], [INFOTRIEVE], [CROSSREF]
- van Dam F. S., Schagen S. B., Muller M. J., Boogerd W., van der Wall E., Droogleever Fortuyn M. E., Rodenhuis S. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. Journal of the National Cancer Institute 1998; 90(3)210–218, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Welsh K. A., Breitner J. C. S., Magruder-Habib K. M. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 1993; 6: 103–110
- Wieneke M. H., Dienst E. R. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-oncology 1995; 4: 61–66, [CSA]